Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/7/2015 |
| Start Date: | December 2011 |
| End Date: | July 2014 |
| Contact: | Kathleen B Sayles, BSN |
| Email: | ksayles@valleyhealth.com |
| Phone: | 201 447 8453 |
Randomized Comparison of Catheter Ablation Versus Anti-arrhythmic Drug Therapy in Patients With Recently Diagnosed Paroxysmal Atrial Fibrillation as Assessed by a Continuous Implantable Monitor
The objective is to compare the progression of Atrial Fib (AF) burden by continuous
monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation
(PVI) versus anti-arrhythmic drug (AAD) therapy.
monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation
(PVI) versus anti-arrhythmic drug (AAD) therapy.
Randomized, multicenter clinical trial comparing medical therapy (Group I) with ablation
therapy(Group II). Randomization will be determined by opening a sealed envelope. All
patients will be implanted with an implantable loop recorder and followed every three
months.
therapy(Group II). Randomization will be determined by opening a sealed envelope. All
patients will be implanted with an implantable loop recorder and followed every three
months.
Inclusion Criteria:
- Patients with recently diagnosed paroxysmal AF who are eligible to receive specific
rhythm control therapy
Exclusion Criteria:
- Previous treatment with Class IC or class III AAD
- Previous AF ablation procedure
- Congestive heart failure (NYHA III-IV functional class)
- Left Ventricle ejection fraction less than 35%
- Left atrial diameter > 55mm
- Unwillingness to participate
We found this trial at
1
site
Click here to add this to my saved trials
